Modified Mitochondria Augmented - Cell Therapy

Mitochondrial-Augmented
Cell Therapy

MitoTherapy Products are novel medicinal products using mitochondria isolated from human stem cells or human blood. Mitochondria are unique organelles that are responsible for energy production in cells. Based on our experimental results, mitochondria have a high potential to treat inflammatory diseases.

Mitochondria-augmented Cell Preparation - Harnessing Patient-Derived Cells to Restore Cellular Energy and Function

We combine autologous stem cells with functional mitochondria to enhance cellular health and therapeutic potential. This process ensures a personalized and biocompatible approach for mitochondrial-based regenerative treatments.

Cells are collected from the patient

The patient’s own stem cells are harvested, either from blood (which is called hematopoietic stem cells/HSCs), SVF (adipose mesenchymal stem cells/ADMSCs), or bone marrow (bone marrow stem cells/BMSc).

Mitochondria is incorporated into the cells

Our GMP-grade functional healthy mitochondria is added into the cells to form mitochondria-augmented stem cells.

The michoria-augmented stem cells are injected into the patient

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla quis pulvinar turpis, id pulvinar nibh. Nunc aliquet mi felis, a egestas neque sodales quis. Donec varius lorem vitae risus pharetra blandit.

GMP Facility : Ensuring Excellence in Mitochondrial Cell Therapy Production

At PAEAN Biotechnology, our GMP (Good Manufacturing Practice) facility upholds the highest international standards for quality and safety. We are committed to meticulous control at every stage, from raw material sourcing to final product formulation.

Equipped with advanced technology and expert personnel, our facility ensures the purity, potency, and safety of our mitochondrial cell therapies. This rigorous approach underpins our mission to deliver innovative and reliable treatments to patients.